Life-Saving, Dose-Adjusted, Targeted Therapy in a Patient with a STAT3 Gain-of-Function Mutation.
Sarfati E, Hadjadj J, Fusaro M, Klifa R, Grimaud M, Berteloot L, Hadchouel A, Godot C, Stolzenberg MC, Frémond ML, Pressiat C, Molina T, Fischer A, Picard C, Renolleau S, Rieux-Laucat F, Blanche S, Neven B.
Sarfati E, et al.
J Clin Immunol. 2021 May;41(4):807-810. doi: 10.1007/s10875-020-00914-3. Epub 2021 Jan 11.
J Clin Immunol. 2021.
PMID: 33428086
No abstract available.